| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | JUNO THERAPEUTICS INCORPORATED | 2,168,601 | 40,878,000 | 84.62% | ||
| 2 | ADMA BIOLOGICS, INC. | 1,433,304 | 7,339,000 | 15.19% | ||
| 3 | MABVAX THERAPEUTICS HOLDINGS, INC. | 26,708 | 90,000 | 0.19% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-17-001771, filed 2017.02.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
